A detailed history of Balasa Dinverno & Foltz LLC transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Balasa Dinverno & Foltz LLC holds 2,079 shares of ZBH stock, worth $223,076. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,079
Previous 2,076 0.14%
Holding current value
$223,076
Previous $218,000 0.46%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022

BUY
$101.65 - $119.27 $304 - $357
3 Added 0.14%
2,079 $217,000
Q2 2022

Aug 09, 2022

SELL
$102.23 - $133.85 $24,535 - $32,124
-240 Reduced 10.36%
2,076 $218,000
Q1 2022

Apr 25, 2022

SELL
$108.42 - $129.58 $2,168 - $2,591
-20 Reduced 0.86%
2,316 $296,000
Q3 2021

Oct 26, 2021

SELL
$136.35 - $158.76 $409 - $476
-3 Reduced 0.13%
2,336 $342,000
Q2 2021

Jul 23, 2021

BUY
$152.95 - $173.41 $11,471 - $13,005
75 Added 3.31%
2,339 $376,000
Q1 2021

Apr 29, 2021

BUY
$148.16 - $159.71 $444 - $479
3 Added 0.13%
2,264 $362,000
Q4 2020

Jan 26, 2021

BUY
$128.25 - $151.41 $18,468 - $21,803
144 Added 6.8%
2,261 $348,000
Q2 2020

Aug 07, 2020

SELL
$87.02 - $133.4 $20,884 - $32,016
-240 Reduced 10.18%
2,117 $253,000
Q1 2020

Apr 30, 2020

BUY
$78.28 - $155.73 $15,108 - $30,055
193 Added 8.92%
2,357 $238,000
Q4 2019

Jan 22, 2020

BUY
$127.4 - $146.83 $11,466 - $13,214
90 Added 4.34%
2,164 $324,000
Q3 2019

Nov 06, 2019

SELL
$113.33 - $138.46 $10,199 - $12,461
-90 Reduced 4.16%
2,074 $285,000
Q2 2019

Aug 07, 2019

BUY
$108.87 - $125.09 $1,850 - $2,126
17 Added 0.79%
2,164 $255,000
Q1 2019

May 10, 2019

SELL
$97.5 - $125.79 $2,730 - $3,522
-28 Reduced 1.29%
2,147 $274,000
Q4 2018

Feb 04, 2019

BUY
$94.4 - $126.76 $205,320 - $275,703
2,175 New
2,175 $226,000

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $22.5B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Balasa Dinverno & Foltz LLC Portfolio

Follow Balasa Dinverno & Foltz LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.